Octarine Bio (private company)

See something wrong or missing? Let us know
Offices:Copenhagen
Business model:B2B

Octarine Bio is a synthetic biology company developing superior cannabinoid and psilocybin derivatives for the pharmaceutical industry.

Investors: we tracked 4 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 3M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Octarine Bio

Name Criteria
Sweden Nanolyze
72%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Beckley Psytech
70%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
United Kingdom Baseimmune
70%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
United Kingdom Causaly
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
France Pharmedigroup
68%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France PEP-Therapy
68%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Finland FinnAdvance
67%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
France Xenothera
67%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
Sweden Pila Pharma
65%
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Poland Molecule.one
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 1M - 5M USD
Top